Connection
Grover Miller to Biological Availability
This is a "connection" page, showing publications Grover Miller has written about Biological Availability.
|
|
Connection Strength |
|
 |
|
 |
|
0.187 |
|
|
|
-
Schleiff MA, Payakachat S, Schleiff BM, Swamidass SJ, Boysen G, Miller GP. Impacts of diphenylamine NSAID halogenation on bioactivation risks. Toxicology. 2021 06 30; 458:152832.
Score: 0.187